Patients with autoimmune disorders have more immune-related side effects to immunotherapy

A study published in The Oncologist recently shows that patients with pre-existing autoimmune disorders are at an increased risk of developing immune-related side effects when treated with immunotherapy. This is regardless of tumour type, gender and general wellbeing. However, these patients can still be treated with immunotherapy. The study included 751 patients with four different […]

read more

What to expect: Enrolling on a cancer clinical trial during the COVID-19 pandemic

The COVID-19 pandemic has resulted in a number of changes to patient care, particularly in hospitals with high numbers of COVID-19 cases. For some patients with cancer, the pandemic has resulted in changes to their treatment and/or the replacement of in-person hospital visits with virtual patient assessments. The COVID-19 pandemic has also led to adaptations […]

read more

Get cancer symptoms checked out

The NHS has launched a programme to encourage patients to have any potential cancer symptoms checked out: NHS staff have worked hard to ensure that cancer services have been maintained throughout the pandemic. Between March and September, over 1 million people were referred by their GP with suspected cancer, and over 291,000 cancer treatments were […]

read more

NHS to trial innovative cancer blood test

The NHS is trialling an innovative new blood test that may be able to detect more than 50 types of cancer. The Galleri blood test, developed by a company called GRAIL, will be piloted with 165,000 patients. Prior research on patients with signs of cancer has already found that the test, which checks for molecular […]

read more

Most coronavirus-positive cancer patients are asymptomatic

Most studies have shown that many cancer patients are at high risk of developing severe forms of COVID-19. In a study of nearly 900 cancer patients with coronavirus in the UK, for instance, the death rate was estimated to be 33.6%, which is much higher than the general population. However, most of these patients were […]

read more

NHS England need for new diagnostic services

A report from NHS England has found that the COVID-19 pandemic has identified a need for a ‘radical change’ in diagnostic services across the country. This report was close to publication before the pandemic identified additional actions needed to deliver higher quality diagnostic services. As part of this ‘radical change’ NHS England identified a number […]

read more

Burnout among cancer professionals during COVID-19

Two online surveys presented at the European Society of Medical Oncology (ESMO) outlined the extent to which the COVID-19 pandemic has affected burnout, job performance, and wellbeing in the global oncology workforce. The first survey included 1520 people from 101 countries between 16 April and 3 May 2020. Of these, 38% stated that they had […]

read more

How the coronavirus pandemic may affect cancer clinical trials

In this article published in Cancer Therapy Advisor this week, changes to how clinical trials are being conducted due to the health risks posed by COVID-19 to cancer patients are discussed. Some of these changes include the use of telemedicine visits, electronic signatures for signing patient consent forms, posting oral medicines to patients’ homes, and […]

read more

Scotland’s plan to remobilise and redesign cancer services

The Government in Scotland has published a new plan to remobilise NHS cancer care to put the experience of patients at its heart. It will focus on improving services and ensuring that all patients have access to the best possible treatments. The coronavirus (COVID-19) pandemic has resulted in significant changes to the war cancer services […]

read more
Showing 1 to 10 of 143 results
  TOP